Group 1 - XianDao Intelligent has set the final price for its H-share public offering at HKD 45.8 per share, with expected listing on February 11, 2026 [1] - Jida Communication is a candidate for a project with China Mobile, with an estimated service fee of approximately CNY 51.04 million [2] - Bowei Alloy's controlling shareholder plans to increase holdings by CNY 100 million to 150 million from February 10 to August 9, 2026 [3] Group 2 - Xiamen Airport reported 16,368 aircraft takeoffs and landings in January 2026, a year-on-year decrease of 4.82%, with passenger throughput of 2.38 million, down 3.84% [4] - Yitong Century has won a bid for a project worth CNY 107 million, providing comprehensive maintenance services for China Tower [5] - Huayi Brothers' controlling shareholder's 70 million shares are subject to judicial auction, representing 42.89% of his holdings and 2.52% of the company's total shares [6] Group 3 - Lianhuan Pharmaceutical received approval for the sale of Tadalafil tablets (20mg) in Ghana [7] - Aonong Biological reported a pig sales volume of 166,600 in January 2026, a year-on-year increase of 35.36% [8] - Xiantan Co. achieved chicken product sales revenue of CNY 546 million in January 2026, a year-on-year increase of 54.9% [9] Group 4 - Zhengbang Technology reported a January sales revenue of CNY 816 million from pig sales, a year-on-year increase of 19.69% [10] - Qianjin Pharmaceutical's net profit for 2025 grew by 24.74% to CNY 288 million [11] - Xinhua Pharmaceutical received a drug registration certificate for glucosamine sulfate capsules [12] Group 5 - Yuandong Bio completed the first dosing of its EP-0210 monoclonal antibody in a Phase I clinical trial for inflammatory bowel disease [13] - Jiaokong Technology signed a contract for the Sydney Metro West Line signal system subcontracting project worth AUD 93.53 million [14] - Dangsheng Technology signed a strategic cooperation framework agreement with Huineng Technology in solid-state batteries and the new energy industry [15] Group 6 - Jinhui Co. plans to acquire 100% of Fusheng Mining for CNY 210 million [16] - Cangzhou Mingzhu announced Guangzhou Light Industry as its new controlling shareholder after a share transfer [17] - Dingxin Technology's vice president was fined CNY 120,000 for short-term trading [18][19] Group 7 - China Modern Pharmaceutical's subsidiary passed a GMP compliance inspection for its production line [20] - Chaosheng Electronics plans to increase capital by CNY 400 million in its subsidiary to enhance competitiveness [21] - Lonyu Mountain reported a 25.03% year-on-year increase in pig sales revenue in January 2026 [22] Group 8 - Sanbo Brain Science's chairman has been released from investigation, and the company is operating normally [23] - Hainan Mining is planning to acquire control of Luoyang Fengrui Fluorine Industry and will resume trading on February 10, 2026 [24] - Dongwei Technology's net profit for 2025 increased by 86.81% [25] Group 9 - Yuanjie Technology plans to invest CNY 1.251 billion in a semiconductor chip and device R&D production base [26] - Metro Design signed a contract for an energy management project with Guangzhou Metro Group worth CNY 924 million [27] - Zhongmin Energy intends to acquire 51% of Fujian Yongtai Mintou Pumped Storage Co. for CNY 864 million [28] Group 10 - Dianzhi Technology plans to repurchase shares worth CNY 100 million to 200 million [29] - China Baoan was not selected as a restructuring investor for the Singshan Group [30] - Zhiguang Electric's subsidiary signed a CNY 1.004 billion contract for energy storage systems [31] Group 11 - Zhifei Biological received approval for a clinical trial of its herpes zoster vaccine [32] - KQ Bio received a new veterinary drug registration certificate for a vaccine against porcine circovirus type 2 [33] - Huanxu Electronics reported a 4% year-on-year increase in consolidated revenue for January 2026 [34] Group 12 - Xiangjia Co. reported a 10.42% year-on-year increase in live poultry sales revenue in January 2026 [35] - Kemin Foods' subsidiary reported a 68.29% year-on-year increase in pig sales revenue in January 2026 [36] - Liyuan Technology signed a procurement contract worth CNY 54.98 million [37] Group 13 - Jiuqiang Bio received a medical device registration certificate for a fibrin degradation product detection kit [38] - Zhongguancun's subsidiary passed the consistency evaluation for Tramadol Hydrochloride tablets [39] - Rundou Co. received a drug registration certificate for Candesartan Etil [40]

格隆汇2月9日丨博威合金(601137.SH)公布，公司于2026年2月9日收到博威集团通知，基于对公司未来 持续稳定发展的信心和长期投资价值的认可，增强投资者信心，博威集团拟以自有和自筹资金通过上海 证券交易所交易系统以集中竞价的方式增持公司股份，本次增持计划的实施期限为自本公告披露之日起 6个月，本次增持计划不设价格区间；增持总金额不低于人民币10,000万元(含)，不超过人民币15,000万 元（含），资金来源为自有资金和自筹资金。 ...

智通财经APP讯，博威合金(601137.SH)发布公告，公司于2026年2月9日收到控股股东博威集团通知，基 于对公司未来持续稳定发展的信心和长期投资价值的认可，增强投资者信心，博威集团拟以自有和自筹 资金通过上海证券交易所交易系统以集中竞价的方式增持公司股份。本次增持计划的实施期限为自公告 披露之日起6个月，本次增持计划不设价格区间;增持总金额不低于1亿元(含)，不超过1.5亿元(含)，资金 来源为自有资金和自筹资金。 ...

博威合金（601137）(601137.SH)发布公告，公司于2026年2月9日收到控股股东博威集团通知，基于对 公司未来持续稳定发展的信心和长期投资价值的认可，增强投资者信心，博威集团拟以自有和自筹资金 通过上海证券交易所交易系统以集中竞价的方式增持公司股份。本次增持计划的实施期限为自公告披露 之日起6个月，本次增持计划不设价格区间;增持总金额不低于1亿元(含)，不超过1.5亿元(含)，资金来源 为自有资金和自筹资金。 ...

每经头条（nbdtoutiao）——美国名校毕业刚回国，26岁"金少"空降成董事长和总经理，父母隐退！A股 多位"00后"执掌要职，"不负投资者"成重大考验 （记者 曾健辉） 每经AI快讯，博威合金2月9日晚间发布公告称，宁波博威合金材料股份有限公司于2026年2月9日收到 控股股东博威集团通知，基于对公司未来持续稳定发展的信心和长期投资价值的认可，增强投资者信 心，博威集团拟以自有和自筹资金通过上海证券交易所交易系统以集中竞价的方式增持公司股份。本次 增持计划的实施期限为自本公告披露之日起6个月，本次增持计划不设价格区间；增持总金额不低于人 民币1亿元(含)，不超过人民币1.5亿元（含），资金来源为自有资金和自筹资金。 ...

证券代码：601137 证券简称：博威合金 公告编号：临 2026-025 宁波博威合金材料股份有限公司关于 控股股东增持公司股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 增持主体的基本情况：本次增持主体为博威集团有限公司（以下简称"博 威集团"），为公司控股股东，本次增持计划实施前，博威集团持有公司股份 231,314,181 股，占公司目前总股本的 25.19%。 增持计划的主要内容：本次增持计划的实施期限为自本公告披露之日起 6 个月，本次增持计划不设价格区间；增持总金额不低于人民币 10,000 万元(含)， 不超过人民币 15,000 万元（含），资金来源为自有资金和自筹资金。 增持计划无法实施风险：本次增持计划可能存在因资本市场情况发生变 化或目前尚无法预判的其他风险因素导致增持计划的实施无法达到预期的风险， 敬请广大投资者注意投资风险。 宁波博威合金材料股份有限公司（以下简称"公司"）于 2026 年 2 月 9 日 收到博威集团通知，基于对公司未来持续稳定发展的信心和长 ...

证券代码：601137 证券简称：博威合金 公告编号：临 2026-026 宁波博威合金材料股份有限公司 关于为全资子公司提供担保的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 担保对象及基本情况 | 担保对 | 被担保人名称 | 博威合金（香港）国际贸易有限公司（以 下简称"博威合金（香港）"） | | | --- | --- | --- | --- | | | 本次担保金额 | 24,000 | 万元 | | 象 | 实际为其提供的担保余额 | 100,000 万元(不含本次) | | | | 是否在前期预计额度内 | 是 □不适用：_________ | □否 | | | 本次担保是否有反担保 | □是 □不适用：_________ | 否 | 累计担保情况 | 对外担保逾期的累计金额（万元） | 0 | | --- | --- | | 截至本公告日上市公司及其控股 | 424,864.52 | | 子公司对外担保总额（万元） | | | 对外担保总额占上市公司最近一 | 50.46 | | ...

南财智讯2月9日电，博威合金公告，公司及全资子公司宁波博威合金精密细丝有限公司共同为全资子公 司博威合金（香港）国际贸易有限公司提供人民币24000.00万元担保，用于银行综合授信业务，保证方 式为连带责任保证；截至公告日，公司已与中国农业银行股份有限公司宁波高新区分行签订《最高额保 证合同》。本次担保在公司2025年度对外担保计划额度范围内，且被担保方资产负债率超过70%。截至 本公告日，公司实际对外提供担保金额（含本次）为420364.52万元，占公司最近一期经审计净资产的 49.93%，无逾期担保。 ...

每经AI快讯，2月9日，博威合金（601137）公告，控股股东博威集团拟自2026年2月10日至2026年8月9 日通过上交所集中竞价增持A股，增持金额1亿元至1.5亿元，本次计划不设价格区间，资金来源为自有 及自筹资金。 ...

证券日报网讯2月6日，博威合金（601137）在互动平台回答投资者提问时表示，合伙企业对公司负有的 业绩承诺均已履行完成，其看好公司发展并长期和公司一起拼搏奋斗，并取得相应的投资回报，合伙公 司严格按照相关管理办法及规则处置财产份额。 ...